8-K: SeaStar Medical Redeems and Converts Convertible Notes, Eliminating Debt with Investor D

SeaStar Medical Holding Corporation redeemed and converted outstanding convertible notes with Investor D, eliminating this debt and issuing new shares.

Summary

• SeaStar Medical Holding Corporation redeemed $0.7 million of convertible notes held by Investor D.
• The redemption included interest and make-whole payments, as per the terms of the notes.
• Investor D also converted approximately $0.6 million in unpaid principal and $0.7 million in unpaid interest and make-whole amounts.
• The conversion resulted in the issuance of 2,321,429 (92,858 post-reverse split) shares of common stock.
• As of June 6, 2024, there are no remaining outstanding convertible notes held by Investor D.
• Investor D still holds warrants to purchase 3,158,086 (126,323 post-reverse split) shares with a weighted-average exercise price of $0.55 ($13.75 post-reverse split).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as the company has eliminated debt, but there is some dilution of shares. The elimination of debt is a positive step, but the share dilution is a negative.

Positives

• The company has eliminated all outstanding convertible notes held by Investor D, reducing debt.
• The conversion of debt into equity may improve the company's balance sheet.

Negatives

• The conversion of debt resulted in the issuance of 2,321,429 (92,858 post-reverse split) new shares, which could dilute existing shareholders.

Risks

• The issuance of new shares could potentially dilute the value of existing shares.
• Investor D still holds a significant number of warrants, which if exercised, could further dilute existing shareholders.

Management Comments

• The company has not provided any specific management comments in this document.

Industry Context

This announcement is specific to SeaStar Medical's financial restructuring and does not directly relate to broader industry trends or competitors.

Comparison to Industry Standards

• It is common for companies to use convertible notes for financing, especially in the biotech and medical device sectors.
• The conversion of debt to equity is a typical method to improve a company's balance sheet.
• The terms of the conversion, including the 200% conversion amount, are specific to the agreement with Investor D and may not be standard across all companies.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• The company's balance sheet may improve due to the reduction of debt.

Key Dates

Keywords

convertible notes, redemption, conversion, common stock, warrants, debt, equity, Investor D, SeaStar Medical